Editorial: Looking at the Complete Picture: Tackling Broader Factors Important for Advancing the Validity of Preclinical Models in Disease

Affiliations

• ¹ School of Medicine, Western Sydney University, Sydney, NSW, Australia.
• ² The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia.
• ³ Institute of Pharmacology and Toxicology, University of Zurich-Vetsuisse, Zürich, Switzerland.
• ⁴ Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zürich, Switzerland.